Female Sexual Function and Back Pain

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2011 by Bezmialem Vakif University.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Bezmialem Vakif University
ClinicalTrials.gov Identifier:
NCT01420276
First received: August 18, 2011
Last updated: NA
Last verified: August 2011
History: No changes posted
  Purpose

Back paın is a common hormonal disorder in women that may affect the phases of female sexual function (FSD). We investigated sexual function in patients with back paın A total of 54 women with back paın and 27 age matched voluntary healthy women who served as the as control group were evaluated with a detailed medical and sexual history, including a female sexual function index (FSFI) questionnaire and the Beck Depression Inventory. Serum prolactin, dehydroepiandrosterone sulfate, free testosterone, androstenedione, 17alpha-hydroxyprogesterone, estradiol, free thyroxin and thyrotropin were measured. These variables were compared statistically between the 2 groups.


Condition Phase
Female Sexual Function
Phase 4

Study Type: Observational
Study Design: Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Bezmialem Vakif University:

Primary Outcome Measures:
  • Female sexual function [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 54
Study Start Date: September 2011
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Detailed Description:

A total of 54 women with back paın and 27 age matched voluntary healthy women who served as the as control group were evaluated with a detailed medical and sexual history, including a female sexual function index (FSFI) questionnaire and the Beck Depression Inventory. Serum prolactin, dehydroepiandrosterone sulfate, free testosterone, androstenedione, 17alpha-hydroxyprogesterone, estradiol, free thyroxin and thyrotropin were measured. These variables were compared statistically between the 2 groups.

  Eligibility

Ages Eligible for Study:   20 Years to 45 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Female with active sexual life

Criteria

Inclusion Criteria:

  • 20-45 year old
  • Female
  • Active sexual life

Exclusion Criteria:

  • Younger than 20, older than 45 year old.
  • Menopause
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Bezmialem Vakif University
ClinicalTrials.gov Identifier: NCT01420276     History of Changes
Other Study ID Numbers: gbpk1
Study First Received: August 18, 2011
Last Updated: August 18, 2011
Health Authority: Turkey:Bezmialem Vakif University

Keywords provided by Bezmialem Vakif University:
Female sexual function

ClinicalTrials.gov processed this record on August 21, 2014